Clazolam

Clazolam[1] (SAH-1123), also referred to as isoquinazepon, is a drug which is a fused benzodiazepine and tetrahydroisoquinoline derivative.[2] It was developed in the 1960s but was never marketed.[2] It possesses anxiolytic effects and is also claimed to have antidepressant properties.[2][3]

Clazolam

Clinical data
ATC code	None
Identifiers
IUPAC name 2-chloro-5-methyl-5,9,10,14b-tetrahydroisoquino[2,1-d][1,4]benzodiazepin-6(7H)-one
CAS Number	7492-29-7 10171-69-4 (HCl)
PubChem CID	24107
ChemSpider	22534
UNII	YJ53T77095
KEGG	D03531
ChEMBL	ChEMBL1723823
CompTox Dashboard (EPA)	DTXSID50274072
Chemical and physical data
Formula	C18H17ClN2O
Molar mass	312.80 g·mol^−1
3D model (JSmol)	Interactive image
SMILES Clc2ccc1N(C(=O)CN4C(c1c2)c3c(cccc3)CC4)C

See also

• Benzodiazepine
• Tetrahydroisoquinoline

References

1. NL 6510987
2. Triggle DJ (1997). Dictionary of pharmacological agents. London: Chapman & Hall. p. 476. ISBN 0-412-46630-9.
3. Potikha LM, Kovtunenko VA (2009). "Synthesis and properties of 3-aminodihydroisoquinolines". Russian Chemical Reviews. 78 (6): 513–533. Bibcode:2009RuCRv..78..513P. doi:10.1070/RC2009v078n06ABEH004041.